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TLR1-induced chemokine production is critical for
mucosal immunity against Yersinia enterocolitica
Y Sugiura1, K Kamdar2, S Khakpour3, G Young4, WJ Karpus5 and R William DePaolo2
Our gastrointestinal tract is a portal of entry for a number of bacteria and viruses. Thus, this tissuemust developways to
induce antigen-specific T cell and antibody responses quickly. Intestinal epithelial cells are a central player in barrier
function and also in communicating signals from invading pathogens to the underlying immune tissue. Here we
demonstrate that activation of Toll-like receptor 1 (TLR1) in the epithelium leads to the upregulation of the chemokine
CCL20 during oral infectionwith Yersinia enterocolitica. Further, both neutralization of CCL20 using polyclonal antibody
treatment anddeletion of TLR1 resulted in a defect in CCR6þ dendritic cells (DCs), which produce innate cytokines that
help to induce anti-Yersinia-specific T helper 17 (TH17) cells and IgAproduction. These data demonstrate a novel role for
TLR1 signaling in the intestinal epitheliumanddemonstrate that together TLR1 andCCL20 are criticalmediators of TH17
immunity through the activation and recruitment of DCs.
INTRODUCTION
The mucosal immune system must balance tolerogenic res-
ponses against food and commensal microbiota while preser-
ving the ability to mount protective inflammatory responses
against invading pathogens. This delicate balance ismaintained
through the coordinated signals and interactions of a variety of
specialized cells. Besides providing an important barrier bet-
ween invading pathogens and the underlying tissue, intestinal
epithelial cells (IEC) can interact with both the bacteria via
secretion of antibacterial peptides,1 and the immune system
through the production of cytokines and chemokines. Within
the intestinal epithelium is a further specialized tissue called
follicular-associated epithelium (FAE), which is situated over
lymphoid follicles called Peyer’s patches (PPs). M cells within
the FAE directly sample luminal antigens by macro-pinocy-
tosis, permitting the delivery of antigen into the PPs where they
can be taken up by dendritic cells (DC) and presented to naive T
cells. A number of enteric pathogens such as Salmonella
typhimurium2,3 andY. enterocolitica4 have developed strategies
to target the FAE and M cells in order to penetrate the
epithelium and cause disease. The epithelium is able to respond
to invading bacteria by the activation of pattern recognition
receptors such as NOD-like and Toll-like (TLR) receptors.
These receptors recognize conserved pathogen-associated
molecular patterns such as peptidoglycan, flagellin, or lipo-
proteins. TLR activation induces an innate immune response,
which in part, will direct the migration of DCs to the site of the
infection. DCs have the significant task of integrating the
signals derived from pathogens5 but also from the tissue
microenvironment.6,7 The integration of these signals is crucial
to the induction of appropriate CD4 T helper (TH) responses
that can eliminate the pathogen while limiting damage to the
infected tissue.Hence, the recruitment and activation ofDCs by
IEC is a critical step in a fundamental immune cascade leading
to protection against mucosal pathogens.
The trafficking of DCs to the site of inflammation is
dependent upon the secretion of chemokines.8 The chemokine
CCL20 (also known as Macrophage Inhibitory Protein-3a) is
constitutively expressed in the gastrointestinal tract,9 however
stimulation of IEC by inflammatory cytokines,10 bacteria such
as Salmonella Typhimurium11 or the TLR5 ligand, flagellin,12
can also stimulate production of CCL20. CCL20 binds to
CCR6,13,14 a G-protein-coupled receptor expressed on the
surface of leukocytes, including lymphocytes15,16 and DCs.17
CCL20 and its receptor CCR6 have been shown to be impor-
tant for protection against a number ofmucosal infections, such
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as respiratory syncytial virus,18 Helicobacter pylori,19 and S.
Typhimurium.20 Pathological examination of colonic biopsies
revealed CCL20 is elevated in patients with inflammatory
bowel disease (IBD)21 and Genome Wide Association Studies
(GWAS) revealed CCL20 is a susceptibility gene for Crohn’s
disease.22Thesedata indicate thatCCL20 andCCR6have impor-
tant roles in protection against mucosal infection, but are also
implicated in the development ofmucosal inflammatory disease.
Previously we have demonstrated that protective TH17
immunity against oral Y. enterocolitica infection requires
signaling via TLR1.23 In the absence of TLR1, there is also a
deficiency in the accumulation of DCs in the gut-associated
lymphoid tissue after Y. enterocolitica infection. In the present
study, we identify a novel role for TLR1 signaling in the
intestinal epithelium leading to the initiation of DC migration
and ultimately the generation of protective TH17 and IgA
immunity against enteric Y. enterocolitica infection.
RESULTS
CCL20 induction is independent of invasion and type III
secretion but dependent upon TLR1 stimulation
Our previous study demonstrated that TLR1 / mice were
unable to effectivelymount a protectivemucosal TH17 response
during mucosal infection by Y. enterocolitica. This was due to a
defect in the activation of TLR1-deficient DCs through direct
contact withY. enterocolitica, resulting in decreased interleukin
(IL)-6 and ultimately decreased TH17 priming.
23 Interestingly,
TLR1 / mice also had fewer DCs in the mesenteric lymph
node (MLN) 3 days following infection. IECs come in contact
with bacteria during infection and secrete CCL20 to attract
CCR6þ DC to the site of infection.9 After activation, CCR6þ
CD11cþ cells downregulate CCR6 and traffic to draining
lymph nodes, where they present antigens to naive T cells. We
hypothesized that the reduction of DCs observed in theMLNof
TLR1 / micemay be due to a defect in recruitment of DCs to
the site of infection. To address the mechanism of DC
trafficking in TLR1-deficient mice, CCL20 expression was
examined in mucosal tissues 72 h after oral infection with
Y. enterocolitica. Y. enterocolitica-induced CCL20 expression
was reduced in the IECs and PPs of TLR1 / mice compared
with wild-type littermate controls by both protein (Figure 1a)
and messenger RNA (mRNA; Figure 1b). CCL20 expression
was not induced in either the lamina propria (LP) or MLN of
littermate controls or TLR1-deficient mice (Figure 1a, b).
Interestingly, the absence of TLR6, which also forms a
heterodimer with TLR2,24,25 showed no effect on CCL20
production (data not shown), suggesting a specific role for
TLR1 in the IEC for CCL20 expression. To show directly that
CCL20 was being produced by IECs in a TLR1-dependent
manner, IECs and lamina propria immune cells (LPCs) were
isolated using expression of CD13 and CD45. IECs (CD13þ
CD45-) and LPCs (CD13-CD45þ ) were purified from the
ileum of the small intestine from TLR1 / and wild-type
littermate control mice. CCL20 mRNA was measured after
stimulation with TLR ligands or Y. enterocolitica. CCL20
transcript was induced by TLR2/1 ligand and Y. enterocolitica
stimulation of IEC (Figure 1c, left) but not LPC (Figure 1c,
right). These data indicate a TLR1 dependence for CCL20
production in IECs but not LPCs.
A common single-nucleotide polymorphism (SNP) occur-
ring in the transmembrane domain of TLR1 abrogates cell
surface expression and signaling26 and is present in at least 20%
of the human population.27 Using a human IEC line that does
not express TLR128 (data not shown), we examined the ability
of the wild-type TLR1 allele (I602I) and the mutant TLR1 allele
(I602S) to induce CCL20 after transfection. Both the TLR2/1
ligand Pam3Cysk4 and Y. enterocolitica lysate induced
significant levels of CCL20 in IEC transfected with the
wild-type allele (Figure 1d, black bars). However, CCL20
expression was not induced if the IEC were transfected with the
TLR1 I602S (Figure 1d, white bars). Notably, Y. enterocolitica
lysate was still able to induce CCL20 in the Caco-2 cells
transfected with the vector control, which may be due to
stimulation of TLR5 by flagellin11,29 or other TLR agonists.30,31
These data demonstrate that epithelial expression of TLR1 is
essential for the induction of CCL20 after oral Y. enterocolitica
infection and suggests that individuals with the I602S SNP in
TLR1 may be unable to induce CCL20 expression during
mucosal infection by Y. enterocolitica.
Y. enterocolitica harbors genes required for cellular invasion,
such as invA and yadA, or genes encoding two different type III
secretion systems (T3SSs; ysa and ysc). These T3SSs inject
effector proteins, called Ysps (Yersinia-secreted proteins) and
Yops (Yersinia outer proteins), into target cells.32,33 These
effectors have multiple and diverse functions such as impairing
cell signaling, inhibiting actin re-arrangement, or inhibiting
nuclear factor-kB activation.34 Yops have also been shown to
activate intracellular immune pathways.35 A specific effector
protein of theYscT3SS, LcrV, has been shown to be essential for
immune-evasion via IL-10 production36 and is also critical for
the formation of the Ysc T3SS needle.37 In order to determine
whether invasion or the T3SS are important for the induction of
CCL20, Caco-2 cells were transfected with wild-type TLR1
(I602I) and the production of CCL20 was measured after
stimulation with Y. enterocolitica or deletion mutants. The
supernatants were collected and used in a chemotaxis assay
with differentiated human CD34þ DC to determine whether
chemo-attraction occurred in a CCL20-dependent manner.
Supernatants from TLR1 I602I-expressing IECs stimulated
with wild-type Y. enterocolitica (8081) were able to induce the
migration of cells similar to that of recombinant humanCCL20
(rCCL20). However, the addition of neutralizing CCL20
antibody to the supernatant almost completely inhibited the
migration of DCs, confirming a specific role for CCL20 in this
migration (Figure 2a). Supernatants from IECs expressing
wild-type TLR1 induced a CCL20-dependent migration that
proved to be independent of invasion, type III secretion, and
LcrV, as each deletion mutant was able to stimulate CCL20
expression equal to wild-type Y. enterocolitica (Figure 2a).
TLR5 signaling by flagellin has been shown to induce CCL20
expression11,29 and may account for the further reduction seen
in I602S-transfected Caco-2 cells treated with anti-CCL20. To
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determine whether invasion or type III secretion was necessary
for the in vivo expression of CCL20, we isolated IECs from
TLR1 / or littermate control mice infected with Y. entero-
colitica (8081) or the deletion mutants. CCL20 was equally
expressed in the IEC from wild-type Y. enterocolitica as well as
the DlcrV, Dysc, and DinvAmutants (Figure 2b). This was not
due to the attenuation of the strains as increasing the dose by
10- and 100-fold still had no effect on CCL20 production (data
not shown). In accordance with our data in Figure 1a, TLR1-
deficient mice had a defect in CCL20 production from IEC and
this was not altered by infection with the various mutants
(Figure 2b). These data demonstrate that while invasion and
type III secretion effector proteins do not contribute to the
production of CCL20, TLR1 is critical for its induction.
CCL20 is important for survival and clearance of
Y. enterocolitica
Stimulation of IECs and FAE by bacteria has been shown to
induce the secretion of CCL2010,38 and attract CCR6þ cells.11
This interaction has been shown to be important for the
generation of pathogen-specific T cells.20 Previously, we have
shown that the absence of TLR1 signaling increases the
mortality and bacterial burden after oral infection by
Y. enterocolitica.23 Here, we wanted to investigate whether
the induction of CCL20 would similarly impact the pathogen-
esis of mucosal Y. enterocolitica infection. Using a polyclonal
neutralizing antibody against CCL20,18 we treated wild-type
mice every other day after oral infection with Y. enterocolitica.
Compared with control-treated mice, mice receiving the
neutralizing antibody against CCL20 had a more severe disease
phenotype, as evidenced by a highermortality (Figure 3a) and a
10-fold higher bacterial burden in the MLN 3 days following
oral infection (Figure 3b).
TLR1 signaling andCCL20 are critical for the recruitment of
DCs during oral Y. enterocolitica infection
CCR6þ DCs have been shown to have an important role in the
defense against mucosal Salmonella infection.20 These DCs are
rapidly recruited to the PPs, where they are activated to prime
anti-Salmonella T cells.20 To determine whether CCR6þ cells
also have a role in Y. enterocolitica infection, we examined the
PPs for the accumulation of CCR6þCD11cþ cells 48 h after
mucosal Y. enterocolitica infection in TLR1-deficient mice and
mice treated with neutralizing antibody against CCL20.
Untreated wild-type mice or those receiving isotype control
antibody developed an increase inCCR6þ CD11cþ cells after
Yersinia infection (Figure 4a). Consistent with a role for TLR1
in CCL20 induction, mice deficient for TLR1 demonstrated a
significant reduction in the frequency (Figure 4b) and total
number (Figure 4c) of CCR6-expressing DCs during infection.
Importantly, the defect in CCR6þ DC observed in TLR1-
deficient mice looked remarkably similar to the defect observed
in wild-type mice treated with neutralizing anti-CCL20
antibodies (Figure 4a–c). Analysis of CCR6 expression on
B and CD4 T cells in the LP from anti-CCL20-treated or
TLR1 / mice revealed no differences (data not shown). This
may be due to increases in other inflammatory chemokines
induced during infection that recruit adaptive immune cells. To
confirm the importance of TLR1 signaling in the IEC forCCL20
production and the recruitment of CCR6þ DC during
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Y. enterocolitica infection bone-marrow chimera’s were perfor-
med. Lethally irradiated TLR1 / mice reconstituted with
bone marrow from wild-type littermate control mice maintain
the ability to signal via TLR1 in the immune cells, but lack the
ability to signal through TLR1 in the IEC. These mice were
unable to produce CCL20 after Y. enterocolitica infection
(data not shown) and had a significant decrease in the
recruitment of CCR6þ DC compared with wild-type mice
reconstituted with TLR1 / bone marrow cells (Figure 4d).
Overall, these data demonstrate that TLR1 signaling in the
epithelium of the small intestine contributes to the recruitment
of CCR6þ DC during infection by Y. enterocolitica.
The absence of CCL20 results in defective innate cytokine
production, TH17 responses, and anti-Yersinia IgA
The molecular signals that drive anti-bacterial TH17 and
mucosal IgA responses are largely unknown. Even more
enigmatic is the role played by the intestinal epithelium in the
development of TH17 and IgA immunity. Previously, we have
shown that TLR1 deficiency results in a reduction of IL-6 and
IL-23, which impacts the development of TH17 cells and
ultimately IgA production. However, the observed decrease
in TH17 polarizing innate cytokines, such as IL-6, in
TLR1-deficient mice may also be due to initial defects in
the recruitment of DCs to the site of the infection.
In order to demonstrate that CCL20 expression has an
impact on TH17 responses, we examined the PP of anti-CCL20-
treated or TLR1 / mice 3 days after oral infection with
Y. enterocolitica for cytokines important in the induction and
maintenance of TH17 cells. TLR1-deficient mice and mice
treated with anti-CCL20 had significantly less IL-6 and IL-23
levels, but similar levels of IL-10, when compared with
littermate control-treated mice (Figure 5a). In addition, we
observed a significant decrease inYersinia-specific TH17 cells in
the LP 7 days following infection in both TLR1-deficient and
anti-CCL20-treated mice (Figure 5b), consistent with the
hypothesis that the absence of CCL20 and CCR6þ DCs would
lead to an inefficient priming of TH17 cells. Of note, levels of
IL-17 aremore reduced in TLR1 / mice comparedwith anti-
CCL20-treated mice. This is likely due to the fact that in the
absence of TLR1 there is both a reduction in the trafficking of
CCR6þ DC that contribute to TH17 priming and loss of IL-6
and IL-23 production due to lack of direct TLR1 signaling on
MLN DC. However, anti-CCL20 treatment reduces the
trafficking but disseminated Y. enterocolitica would still be
able to stimulate IL-6 and IL-23 from DC in the MLN. Our
work23 and others39 have shown that IL-17 is important for the
induction ofmucosal IgA, which is important for the protection
against mucosal pathogenic infections. We evaluated Yersinia-
specific fecal IgA in our anti-CCL20-treated mice and found a
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significant reduction compared with control-treated mice
(Figure 5c).
As CCL20 expression was important for TH17 and IgA
production, we hypothesized that the CCR6þ DC are the cells
producing IL-6 and IL-23. As a result of this elevated innate
cytokine production, CCR6þ DCs would be able to induce
more TH17 cells. To test this theory, CCR6þCD11cþ cells
were sorted from the PP of infected wild-type mice, and
quantitative reverse transcription (RT)-PCR was performed to
examine whether these cells express more IL-6 and IL-23 when
compared with naive mice. As anticipated, the expression of
both IL-6 and IL-23 were significantly upregulated in the
CCR6þ DC (Figure 5d). Further, CCR6þ DC stimulated
TH17 cell induction as evidenced by IL-17 secretion (Figure 5e,
left) and induction of the transcription factor rorgt (Figure 5e,
right). Finally, to demonstrate that the IL-6 and IL-23 produced
by the CCR6þ DCs were responsible for TH17 cell induction
neutralizing antibodies against IL-6, IL-23, or both were added
to the cultures. IL-17 production in cultures containing
CCR6þ DC was significantly reduced in the presence of
anti-IL-6 or anti-IL-23 and there was an additive effect when
both neutralizing antibodies were added to the culture
(Figure 5f). These data suggest that the recruitment of
CCR6þ DCs during infection is critical for the proper
production of innate cytokines that can polarize TH17
responses and promote microbial clearance.
DISCUSSION
In this study, we demonstrate that TLR1 signaling is critical
for the production of CCL20 by the intestinal epithelium
during infection by Y. enterocolitica. Importantly, these
data confirm and extend observations made by our group,
which revealed a dual role of TLR1 in generating mucosal TH17
and IgA responses during mucosal infection. We identified
that TLR1 was important for the induction of IL-23 and IL-6 by
DCs encountering the pathogen directly, and we also
showed that in the absence of TLR1, there was a defect in
the number of DCs in the MLN.23 The present study
reconciles these findings by illustrating that TLR1 signaling
in IEC induces CCL20. In the absence of TLR1 or CCL20, there
is a defect in the recruitment of CCR6þ DC to the PPs.
This population of DC is particularly important because they
produce IL-6 and IL-23, and promote anti-Yersinia TH17
responses in the LP.
Y. enterocolitica has developed a number of virulence
strategies to avoid or inhibit the immune system. The
expression of invasin and YadA allow the attachment to
and uptake by M cells of the FAE.4,40 Y. enterocolitica also uses
T3SS to inject effector proteins (Ysps and Yops) into host target
cells. These effectors can affect a wide variety of cellular
functions, such as apoptosis, nuclear factor-kB activation, and
phagocytosis.34 One effector protein secreted by the Ysc T3SS is
called LcrV. LcrV is important for the injection needle,37 as well
as a potent inducer of IL-10 via signaling through TLR2/6
heterodimers.36 Using mutants for invasion and type III
secretion, we found that CCL20 levels were not dependent upon
these virulence factors. Importantly, infection of TLR1-
deficient mice with the mutant Yersinia still resulted in
decreased CCL20 production, and thus the induction is likely
due to lipoproteins on the surface of Yersinia contacting
surface expressed TLR1 on IEC, however, the identity of the
particular agonist is unknown but is currently under investiga-
tion in our laboratory. The ability to recruit DC and activate
adaptive immunity using TLR1 signaling even in the context of
these potent virulence factors is crucial for protective immunity
by the host.
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Previous studies have shown that CCL20 production and
recruitment of CCR6þ DC occur during infection in mucosal
sites, such as the gut20,41,42 and lung.43 This migration and
activation of mucosal DC has also been shown to be an
important host strategy for the induction of pathogen-specific
effector T-cell responses.18,20 Previous studies have illustrated
that the induction of CCL20 andmigration of CCR6þ DC can
occur in a TLR5-dependent manner, stimulated by flagellins
present on invading bacteria.11,29 Our study does not contradict
a role for TLR5 in CCL20 production. In fact, Caco-2 cells,
which express TLR511 but not TLR128 (data not shown), were
able to produce CCL20 when stimulated with Y. enterocolitica.
Notably, when wild-type human TLR1 (602I) was transfected
into theCaco-2 cells, therewas an increase inCCL20, indicating
that these two TLR receptors may synergize to promote higher
CCL20 levels. Interestingly, when TLR1 contained a SNP that
prevents cell surface expression, there was no change in the
levels of CCL20. This SNP is particularly interesting because it
has been associated with mucosal disease such as IBD.44
However, the effect that TLR1 deficiency has on mucosal
immunity has never been fully examined. These data suggest
that the absence of TLR1 signaling may result in aberrant DC
activation and a defect in antigen-specific priming of effector
T cells. How these defects may contribute to autoimmunity
and infection is currently under investigation.
Although TLR2/1 signaling inDChas been shown to activate
a gut-specific phenotype,45 very little is known about the role of
TLR1 activation in the intestinal epithelium of the small
intestine. The present study demonstrates a profound defect in
CCL20 production from the intestinal epithelium in the
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Figure 5 Absence of CCL20 impacts interleukin (IL)-17 priming and IgA secretion. (a) Levels of IL-23, IL-6, and IL-10 in the Peyer’s patch of
TLR1 / or anti-CCL20-treatedmice infected orallywithY. enterocolitica. Data are themean±s.e.m. pooled from two independent experiments (n¼ 6).
(b) Levels of IL-17 from isolated LP CD4 T cells re-stimulated with irradiated antigen-presenting cell and Y. enterocolitica lysate. Data are the
mean±s.e.m. pooled from two independent experiments (n¼6). (c) Fecal anti-Yersinia IgA levels frommice collected at day 14 post infection. Data are
pooled from two independent experiments (n¼ 6 mice per group). (d) Messenger RNA (mRNA) levels of IL-6 and IL-23 from CCR6þ and CCR6-
CD11cþ sorted Peyer’s patch cells 3 days post infection. Fold induction is compared with uninfected controls. Data are pooled from two independent
experiments (n¼ 5–6 mice per group). (e) Purified CCR6þ and CCR6- dendritic cells (DCs) were sorted from wild-type mice infected with
Y. enterocolitica. The purified DCs were co-cultured with CD4þ ovalbumin-specific T cells (OT2) and ovalbumin. Supernatants were analyzed after
3 days for levels of IL-17 (left). CD4 T cells were sorted from the co-cultures and mRNA level of the transcription factor for rorgt was determined.
(f) Levels of IL-17 in co-cultures similar to those in 5e with the addition of neutralizing antibodies to IL-6 and IL-23. Data are the average±s.e.m.
pooled from three independent experiments. *Po0.01, **Po0.01 (Student’s unpaired t-test).
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absence of TLR1 signaling. Although this is the first study that
defines a role for TLR1 in the intestinal epithelium, studies have
defined a role for its co-receptor, TLR2, in mucosal immunity.
TLR2 signaling has been shown to be important for mucosal
repair46 and regulation of intestinal barrier function.47 How-
ever, these studies were performed onmice with deletion of the
TLR2 gene. Consequently, heterodimers with either TLR6 or
TLR1 would be unable to form, thus impacting signaling via all
three receptors. Here, we show a protective role for TLR1
during bacterial infection via its signaling in the intestinal
epithelium. Taken together with our previous work, we show
that TLR1 can have multiple, non-redundant roles depending
upon the tissue or the type of cell onwhich it is expressed. TLR1
signaling in the epithelium induces CCL20 and recruits DC
important for generating anti-Yersinia TH17 cells. However,
TLR1 signaling in MLN DC produce IL-6 and IL-23, but not
CCL20. These data confirm that the context and tissue in which
the pathogen is detected ultimately determines the type of
immune response induced.
This study defines TLR1 as a critical receptor involved in the
initiation of immune response via migration and activation of
DC in the gut-associated lymphoid tissue and ultimate
clearance of mucosal pathogens through the induction of
effector TH17 cells. The early events of an immune response are
critical for the control and containment of the pathogen, as well
as recruiting professional antigen-presenting cells to the site of
infection. During mucosal infection, pathogens will interact
with the intestinal epithelium, so the ability of these cells to
communicate with the immune system and signal to DC is
critical for the generation of anti-bacterial or anti-viral T-cell
responses. Here, we demonstrate that TLR1 signaling in the
epithelium induces the production of CCL20. The production
of CCL20 recruits DC that function to phagocytose
Y. enterocolitica and induce anti-Yersinia TH17 cells. Thus,
TLR1-signaling links the innate responses and the adaptive
response via the recruitment and activation of CCR6þ DC.
Although the data presented here demonstrate that TLR1
activates DCs during pathogenic infection, there remains a
possibility that TLR1 could also trigger DC activation against
commensal microbiota if the mucosal barrier is damaged
during inflammation. This is especially intriguing, as both
CCL20 and CCR6 have been identified as susceptibility genes
in Genome Wide Association Studies for IBD.22 However, the
molecular mechanism for the induction of CCL20 during IBD
has not been clearly defined.
In summary, our study expands upon our understanding of
howTLR1may inducemucosal TH17 responses and identifies a
novel role for TLR1 at the intestinal epithelium via induction of
CCL20 and activation ofmucosal DC. These data are important
as they suggest that stimulation of TLR1 during vaccination or
infection would promote immunity, generation of pathogen-
specific T cells, antibody production, and eventual clearance of
the bacteria. Alternatively, inhibition of TLR1 may dampen
chronic inflammation by inhibiting the generation of antigen-
specific TH17 cells, which may provide a therapy for patients
with mucosal autoimmune disease or IBD.
METHODS
Mice. TLR1 / mice were generously provided by S. Akira and then
bred to C57BL/6 mice. Wild-type littermates were used as controls,
unless otherwise noted in figure legends. All mice were maintained at
TheUniversity of SouthernCalifornia and all animal experiments were
performed in accordance with institutional guidelines.
Bonemarrow chimera’s. TLR1 / and wild-type littermate control
mice were lethally irradiated with 1,000 cGy. The mice were
reconstituted intravenously with 10 106 cells isolated from donor
bonemarrow. After 3 weeks, themice were infected orally with 1 106
c.f.u.Y. enterocolitica. At the time of collection, isolated LPCs and IECs
were assayed for expression of TLR1 to confirm the reconstitution.
Bacterial growth, cultureand infections. Y. enterocolitica strain 8081
and variousmutantsDlcrV,Dysc,DinvAwere grownovernight at 26 1C
in tryptic soy broth (BD Biosciences, San Jose, CA). Following
overnight incubation, each strain was subcultured by a 1:100 dilution
into fresh growth medium and further incubated for 2 h. Bacterial
density wasmeasured by OD at 600 nM and diluted to 1 106 c.f.u. per
ml in sterile phosphate-buffered saline (PBS). Mice were administered
100 ml by intragastric gavage. Custom-made goat anti-murine CCL20
was prepared by Invitrogen Life Technologies (Grand Island, NY) by
multiple site immunization of a goat with recombinant mouse CCL20
(R&D System, Minneapolis, MN) emulsified in Complete Freund’s
Adjuvant. Antiserum was titrated by sandwich ELISA and specificity
was verified by the failure to cross-react with any other chemokine
tested (e.g., mouse CXCL10, CXCL12, CCL5, CCL3, CXCL13, CCL2,
CCL21, and CCL22). In some experiments, mice were treated
intraperitoneally with polyclonal anti-CCL20, and as a control goat
IgG (R&D Systems), beginning at the time of infection and then every
other day for 5 days. Bacterial burden was determined following the
collection of MLN, which were homogenized in sterile PBS. Samples
were then serially diluted in sterile PBS, plated onto Trypic Soy Agar
plates (BD Biosciences) and grown for 48 h at 26 1C.
Yersinia-specificAntibodyELISA. Ninety-six-well plates were coated
with 10mgml 1 Y. enterocolitica lysate overnight at 4 1C prepared as
previously described.36 Briefly, strain 8081 was grown as described
above. The bacteriawas pelleted and reconstituted in 0.5ml sterile PBS.
Silicon beads were added to the bacteria and the solution was lysed
using a bead beater (Biospec, Bartlesville, OK) for 5min. Protein
determinationwas performed on the lysate and 100 ml lysatewas plated
to confirm all the bacteria were killed. Fecal samples were prepared by
collecting fresh fecal pellets that were dissolved in 1ml lysis buffer
containing soybean trypsin. Undiluted fecal supernatants were added
to bacteria-coated plates for 2 h at room temperature. Plates were
washed and then incubated with HRP-conjugated anti-mouse IgA
(Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-mouse IgG1,
rabbit anti-mouse IgG2a, or rabbit anti-mouse IgM followed by
anti-Rabbit HRP (BD Biosciences). 3,30-5,50-tetramethylbenzidine
substrate (Dako, Carpinteria, CA) was used for detection and absor-
bance was read at 495 nmOD. Antibody titers were detected by ELISA
and calculated according to the formula: (OD450nm sampleOD450nm
of blank)  serum dilution, where OD is optical density.
Detection of cytokines. Isolated IEC, LP, and MLN cells were
collected and prepared for ELISA as previously described.48 Quan-
tification of CCL20 by ELISA (R&D Systems) was performed by
manufacturers specifications. For the detection of IL-17 in response to
Yersinia, LP cells were isolated as previously described48 and the cells
were stimulated with 10mgml 1 Y. enterocolitica lysate prepared as
described.23 The supernatants were collected after 24 h and IL-17 was
detected by ELISA (R&D Systems).
Caco-2 transfections. Caco-2 cells (ATCC CRL-2102) were co-
transfected with a vector expressing TLR1 I602I (wild type) or a SNP in
TLR1 I602S (generously donated byDrRichardTapping, University of
Illinois at Urbana-Champaign). This vector also expresses the firefly
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luciferase gene driven by the IL-8 promoter and pRL-null, a Renilla
luciferase transfection control (Promega,Madison,WI). Transfections
were performed using FuGENE 6 at a lipid-to-DNA ratio of 4:1 (Roche
Applied Science, Indianapolis, IN). The total amount of transfected
plasmid DNA was equalized by supplementing with empty vector,
pFLAG-CMV. Two days post transfection the cells were stimulated
with the TLR1/2 agonist (Pam3CysK4) (Invivogen), TLR6/2 agonist
(FSL-1; Invivogen), TLR4 agonist (LPS; Sigma), or Y. enterocolitica
lysate for 18 h, and cell lysates were collected. Firefly luciferase and
Renilla luciferase enzyme activities were determined using the
luciferase assay system (Promega, Madison, WI) according to the
manufacturer’s instructions. Firefly luciferase activity was normalized
to that of Renilla luciferase activities to correct for the transfection
efficiency. After correcting for transfection efficiency, all values were
normalized to those of unstimulated cells transfected with reporters
and empty FLAG-CMV vector.
Flow cytometry. PP cells (0.5 1 106) were washed and incubated
with anti-mouse FcRII/III (CD16/32 clone 2.4G2; BD Biosciences) for
15min at 4 1C to prevent nonspecific Fc binding. Cells were washed in
PBS with 10% BSA (Sigma Aldrich, St Louis, MO) and stained with a
live/dead marker (7-AAD) before being labeled directly with
monoclonal antibodies specific for lymphocyte surfacemarkers (CD13
FITC, CD11c FITC, CD45 APC-Cy7, and CCR6 PE; BD Biosciences)
at 4 1C for 15min. Expression was determined on a FACSCanto flow
cytometer (BD Biosciences) using FloJo software.
DCandTcell co-culture. CCR6þ or CCR6-DCswere sorted from the
PP of wild-type mice infected with Y. enterocolitica for 3 days. 5 104
DCs were co-cultured with 1 105 naive CD4 T cells isolated from
OT2mice in the presence or absence of 10 mg ovalbumin for 3 days. IL-
17 levels were measured by ELISA. In some experiments, CD4 T cells
were sorted from the co-culture using anti-CD4 microbeads (Miltenyi
Biotech, Bergish Gladbach, Germany) and mRNA levels of rorgt were
measured by quantitative RT-PCR or the addition of 1 mgml 1 anti-
IL-6 (R&D Systems) and anti-IL-23 (R&D Systems) were added to the
cultures.
Quantitative RT-PCR. Tissue RNA was isolated from Peyer’s patch
using TRIzol reagent (Life technologies). RNA was transcribed into
cDNA using the iScript cDNA synthesis kit (Bio-Rad Laboratories,
Irvine, CA). Quantitative real-time RT-PCR was performed on an
iCycler iQ real-time PCR detection system (Bio-Rad Laboratories)
using a SYBr green amplification kit (Bio-Rad Laboratories) with the
following primers, il-6 forward 50-GCCCAGCTATGAACTCCTTCT-
30 and reverse 50-GAAGGCAGCAGGCAACAC-30, il-23 forward
50-GGTGGCTCAGGGAAATGT-30 and reverse 50-GACAGAGCAG
GCAGGTACAG-30, and ccl20 forward 50-AGATGGCCGATGAA
GCTTGTGA-30, ccl20 reverse 50-TCATTTCCTCCTTGGGCTGT
GT-30, rorgt forward 50-ACAGCCACTGCATTCCCAGTTT-30 and
rorgt reverse 50-TCTCGGAAGGACTTGCAGACAT-30. Gene
expression levels for each individual sample were normalized to
GAPDH. Fold changes in gene expression were relative to uninfected
controls and calculated using the DDCt method.
Derivation of human CD34þ DC. CD34þ cells were isolated from
mononuclear fractions of normal human blood purchased from
Bioreclamation (Jericho, NY) using positive selection with anti-CD34-
coated microbeads (Miltenyi Biotec) to a purity of 89–95%. Cells were
cultured in complete medium containing RPMI 1640 (Invitrogen,
Breda, The Netherlands) supplemented with 8% heat-inactivated fetal
calf serum (FCS) (Hyclone; Thermo Fisher Scientific, Rockford, IL),
10mM HEPES (Invitrogen), 2mM L-glutamine (Invitrogen), 50 mM
b-mercaptoethanol, and penicillin/streptomycin (Invitrogen). From
day 0 to day 6, the cells were cultured in complete medium sup-
plemented with 100 ngml 1 granulocyte macrophage colony-
stimulating factor (R&D systems) and 5% heat inactivated ABþ
pooled human serum (Gemini Bio-Products West Sacramento, CA).
On the final day, the cells were counted and used in the chemotaxis
assay described below.
Chemotaxis Assay. Chemotaxis was performed in triplicate for 2 h in
Boyden chambers (Neuroprobe, Gaithersburg, MD). Supernatants
from Caco-2 cells stimulated with Y. enterocolitica, 10mgml 1
rhCCL20 (positive control; R&D Systems), or media alone (negative
control) were added to the top chamber. In all cases, anti-CCL20
(1 mgml 1; R&D Systems) antibody was added to ensure specificity of
migration. A total of 5 105 human-derived CD34þ DCswere added
to the lower wells. After 2 h, the top chambers were harvested and
enumerated.
Statistics. Paired and unpaired Student’s t-tests were usedwhen noted
in figure legends. Tests that had an interaction of Po0.05 were
considered significant. Wilcoxon log-rank test was used for analysis of
mouse survival in animal challenge experiments.
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